Eagle Pharmaceuticals, Inc. Derivative Asset
Eagle Pharmaceuticals, Inc. had Derivative Asset of $2.55 million as of 2020-09-30, per its 10-Q filed 2020-11-02.
Discontinued › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2020-11-02
- 2020-09-30: Derivative Asset $2.55M.
| Period end | Derivative Asset |
|---|---|
| 2020-09-30 | $2.55M 10-Q · filed 2020-11-02 |